4
Changes in Ownership
ALNYLAM PHARMACEUTICALS, INC. Filed Acc 0001735276-24-000002
EVP, CLO & Secretary sold 1,591 shares at an average $170.99 ($272,050)
- EVP, CLO & Secretary acquired 5,175 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Franchini Indrani Lall · EVP, CLO & Secretary
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-01 | Exercise or conversion : show line 1 in the form | +5,175 | 5,175 | D | ||
| 2024-02-02 | Sale : show line 2 in the form | −502 | $170.01 | $85,345 | 4,673 | D |
| 2024-02-02 | Sale : show line 3 in the form | −820 | $171.14 | $140,335 | 3,853 | D |
| 2024-02-02 | Sale : show line 4 in the form | −269 | $172.38 | $46,370 | 3,584 | D |
| Open-market sales · 1,591 sh · avg $170.99 · $272,050 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2024-02-01 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −5,175 | 5,175 | 5,175 | D |
Loading xslF345X05/edgardoc.xml…